## Mechanism: 
- Recombinant, humanized antibody Fab fragment conjugated to PEG with specificity for human TNFα➔ neutralizes membrane-bound and soluble TNFα 
## Indications: 
- moderately to severely active RA, Crohn’s disease, moderate to severe plaque psoriasis, active PsA, active AS, non-radiographic axial spondyloarthritis.
## Adverse Effects
- increase the risk of 
	- bacterial infections and macrophage-dependent infections (including tuberculosis, fungal, and other opportunistic infections) 
	- skin cancers—including melanoma